Centene Corporation $CNC Shares Purchased by Personal CFO Solutions LLC

Personal CFO Solutions LLC grew its position in Centene Corporation (NYSE:CNC) by 199.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,296 shares of the company’s stock after purchasing an additional 10,861 shares during the period. Personal CFO Solutions LLC’s holdings in Centene were worth $534,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in Centene by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 56,978,753 shares of the company’s stock valued at $2,344,676,000 after acquiring an additional 190,334 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Centene by 117.0% during the fourth quarter. AQR Capital Management LLC now owns 31,798,738 shares of the company’s stock valued at $1,308,518,000 after purchasing an additional 17,143,904 shares during the period. Geode Capital Management LLC raised its stake in shares of Centene by 5.5% during the fourth quarter. Geode Capital Management LLC now owns 13,271,492 shares of the company’s stock valued at $554,338,000 after purchasing an additional 697,277 shares in the last quarter. Deerfield Management Company L.P. lifted its holdings in Centene by 184.0% in the third quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock worth $322,761,000 after purchasing an additional 5,860,630 shares during the period. Finally, Morgan Stanley grew its position in Centene by 7.2% in the 4th quarter. Morgan Stanley now owns 9,002,570 shares of the company’s stock valued at $370,456,000 after buying an additional 603,585 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.

Centene Trading Up 0.6%

Shares of NYSE CNC opened at $67.47 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $69.29. The company has a market cap of $33.32 billion, a price-to-earnings ratio of -5.14, a P/E/G ratio of 0.53 and a beta of 1.07. The business has a fifty day simple moving average of $61.27 and a 200-day simple moving average of $47.77.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $1.14. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The firm had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. During the same quarter in the previous year, the company earned $2.90 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Sell-side analysts predict that Centene Corporation will post 3.44 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Raymond James Financial set a $75.00 price target on shares of Centene in a research report on Tuesday. Royal Bank Of Canada raised their price objective on shares of Centene from $70.00 to $71.00 and gave the company a “sector perform” rating in a research note on Thursday. Cantor Fitzgerald upped their target price on Centene from $60.00 to $75.00 and gave the stock an “overweight” rating in a research report on Tuesday. TD Cowen reaffirmed a “hold” rating and set a $47.00 price target (up from $38.00) on shares of Centene in a research note on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft upgraded Centene from a “hold” rating to a “buy” rating and lifted their price target for the company from $53.00 to $80.00 in a research report on Wednesday, May 20th. Seven investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $62.50.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.